| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/02/2004 | US6699665 Multiple array system for integrating bioarrays |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 03/02/2004 | US6699658 Yeast cell surface display of proteins and uses thereof |
| 03/02/2004 | US6699657 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses |
| 03/02/2004 | US6699655 Detecting preferential activity in sample; obtain reaction mixture, incubate with fluorescent particle, monitor flourescent polarization |
| 03/02/2004 | US6699654 Antimicrobial agents diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| 03/02/2004 | US6699482 Leptospira rare outer membrane proteins |
| 03/02/2004 | US6699465 Chemical structure for use in the prevention and treatment of viral infections |
| 03/02/2004 | US6699382 Method for analyzing a biological sample |
| 03/02/2004 | US6698583 Urine cup carry-in apparatus |
| 03/02/2004 | US6698274 Micronaire, maturity and fineness measurements via continuous compression air flow permeability measurements |
| 03/02/2004 | US6698273 Method and apparatus for inspecting airtightness of gas sensor |
| 03/02/2004 | CA2149903C Use of capillary electrophoresis for quantitating the concentration of protein components and of the total protein in fluids |
| 03/02/2004 | CA2058175C Methods for determination of an analyte |
| 03/02/2004 | CA2003051C Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization |
| 02/29/2004 | CA2438924A1 Method and system for determining the acceptability of signal data collected from a prothrombin time test strip |
| 02/29/2004 | CA2437642A1 Improvement of specificity in the determination of antithrombin |
| 02/27/2004 | CA2437249A1 Methods of determining glucose concentration in whole blood samples |
| 02/27/2004 | CA2399781A1 Cellular and molecular basis for anti-alzheimer treatment by blocking mrna dendritic transport from cell body to senile plaque and by this the prevention of senile plaque formation |
| 02/26/2004 | WO2004017443A2 Electrochemical cells, and gas sensor and fuel cell devices comprising same |
| 02/26/2004 | WO2004017423A2 Sensor arrangement |
| 02/26/2004 | WO2004017376A2 Integrated system for printing, processing, and imaging protein microarrays |
| 02/26/2004 | WO2004017374A2 Reading of fluorescent arrays |
| 02/26/2004 | WO2004017356A2 Process and apparatus for pulsed dc magnetron reactive sputtering of thin film coatings on large substrates using smaller sputter cathodes |
| 02/26/2004 | WO2004017073A1 Method of detecting allergen protein |
| 02/26/2004 | WO2004017072A1 A cellular assay system for neurofibrillary tangle formation |
| 02/26/2004 | WO2004017070A2 Sensor surface comprising an improved signal-noise ratio |
| 02/26/2004 | WO2004017069A1 Biochip analyzer and online anaylsis system |
| 02/26/2004 | WO2004017068A1 Method of detecting nucleic acid by using dna microarrays and nucleic acid detection apparatus |
| 02/26/2004 | WO2004017067A2 Method and device for classifying meats to quality level according to the colour thereof |
| 02/26/2004 | WO2004017066A1 A system and a method for observing and predicting physiological state of an animal |
| 02/26/2004 | WO2004017065A1 Forced-ventilated measuring device for detecting technical parameters relating to the air |
| 02/26/2004 | WO2004017063A2 Device and method for detecting a substance with the aid of a high frequency piezo-acoustic thin film resonator |
| 02/26/2004 | WO2004017052A2 Histological assessment |
| 02/26/2004 | WO2004017051A1 A method of characterizing dendritic cells |
| 02/26/2004 | WO2004017050A1 Tear film osmometry |
| 02/26/2004 | WO2004017049A2 Capillary rheometer |
| 02/26/2004 | WO2004017048A1 Rheometer |
| 02/26/2004 | WO2004017042A2 Methods and reagents for surface functionalization |
| 02/26/2004 | WO2004017039A2 Methods for identifying a prospective binding site on a target molecule and for characterizing a site on a target molecule |
| 02/26/2004 | WO2004016850A1 On-line pulp digester control system |
| 02/26/2004 | WO2004016807A1 Method for determining free thrombin concentration |
| 02/26/2004 | WO2004016804A2 Assay for detection of antigen in bodily fluid |
| 02/26/2004 | WO2004016802A2 Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| 02/26/2004 | WO2004016800A2 Assay for low molecular weight heparin |
| 02/26/2004 | WO2004016799A2 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 02/26/2004 | WO2004016790A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | WO2004016785A1 Method of examining atopic dermatitis |
| 02/26/2004 | WO2004016784A1 Protease inhibitor |
| 02/26/2004 | WO2004016783A1 Method of examining atopic dermatitis |
| 02/26/2004 | WO2004016781A1 Human-origin proteins forming domain and use thereof |
| 02/26/2004 | WO2004016777A2 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests |
| 02/26/2004 | WO2004016769A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | WO2004016766A2 Real time measurement of cellular responses |
| 02/26/2004 | WO2004016765A2 Method for search based character optimization |
| 02/26/2004 | WO2004016762A2 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016759A2 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 02/26/2004 | WO2004016758A2 Brain endothelial cell expression patterns |
| 02/26/2004 | WO2004016752A2 Proteome-wide mapping of post-translational modifications using endonucleases |
| 02/26/2004 | WO2004016751A2 Methods of treating neurodegenerative diseases |
| 02/26/2004 | WO2004016746A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a c-myc protein |
| 02/26/2004 | WO2004016736A2 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016734A2 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016733A2 Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016729A2 SYSTEMS AND METHODS FOR CONTROL OF pH AND OTHER REACTOR ENVIRONMENTAL CONDITIONS |
| 02/26/2004 | WO2004016727A1 Determination and/or control of reactor environmental conditions |
| 02/26/2004 | WO2004016726A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | WO2004016655A1 ANTIBODY SPECIFIC TO CENTRAL τ-PROTEIN |
| 02/26/2004 | WO2004016644A2 Compositions and methods used for identifying factors required for the agglomeration of proteins |
| 02/26/2004 | WO2004016642A2 ISOFORM SPECIFIC INTERACTIONS OF APOLIPOPROTEIN E TO AN INTERMEDIATE CONFORMATION OF ALZHEIMER Aβ PEPTIDE |
| 02/26/2004 | WO2004016586A2 Compositions and methods related to flavivirus envelope protein domain iii antigens |
| 02/26/2004 | WO2004016360A1 Imprinting a substrate for separation of a target molecule from a fluid medium |
| 02/26/2004 | WO2004016266A1 Methods of treating benzodiazepine site (bzd-s) associated syndromes using 2’ hydroxyflavonoids |
| 02/26/2004 | WO2004016265A1 Methods of predicting gabaa receptor efficacies for flavonoid compounds and uses therefor |
| 02/26/2004 | WO2004016255A1 The use of resveratrol to regulate expression of apolipoprotein a1 |
| 02/26/2004 | WO2004016227A2 Screening methods for cognitive enhancers |
| 02/26/2004 | WO2004016223A2 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity |
| 02/26/2004 | WO2004016212A2 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | WO2004016171A1 Device and method for in vitro determination of analyte concentrations within body fluids |
| 02/26/2004 | WO2004016156A2 Dynamic hepatic recycling glucose tolerance test |
| 02/26/2004 | WO2004016151A2 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | WO2004016148A2 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors |
| 02/26/2004 | WO2004016102A2 A rapid method for predicting tomato paste consistency |
| 02/26/2004 | WO2004016083A1 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy |
| 02/26/2004 | WO2004016082A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 02/26/2004 | WO2004016065A2 Immunochromatography system and method for the simultaneous identification of aga and t-tg antibodies and use thereof for the diagnosis of celiac disease |
| 02/26/2004 | WO2004003510A3 Fluorescent dyes, energy transfer couples and methods |
| 02/26/2004 | WO2004002413A3 In vivo angiogenesis assay |
| 02/26/2004 | WO2004000881A9 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 02/26/2004 | WO2003106967A9 Method of evaluating myelosuppressive state |
| 02/26/2004 | WO2003105758A3 Cancer-linked gene as target for chemotherapy |
| 02/26/2004 | WO2003104384B1 Reactor systems having a light-interacting component |
| 02/26/2004 | WO2003102581A3 Assay for glycosylated proteins |
| 02/26/2004 | WO2003099222A3 Pseudo-tissues and uses thereof |
| 02/26/2004 | WO2003099105A3 Diagnosis and treatment of human dormancy syndrome |
| 02/26/2004 | WO2003098223A3 A method for killing cells by inhibiting histone activity in the cell |
| 02/26/2004 | WO2003097859A3 Method for producing polymer layers |
| 02/26/2004 | WO2003096020A3 Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) |
| 02/26/2004 | WO2003095942A3 System and method for control of paint thickness by using an optoacoustic technique |
| 02/26/2004 | WO2003095674A3 Methods for evaluating a disease condition by detection of particle and non-particle bound nucleic acids in blood plasma and serum |